Press Release

Streamline Health® Reports Fourth Quarter 2014 Revenues Of $6.6 Million; 2014 Recurring Revenues Of 88%

Streamline Health® Reports Fourth Quarter 2014 Revenues Of $6.6 Million; 2014 Recurring Revenues Of 88% 64.5 KB

ATLANTA, April 16, 2015 /PRNewswire/ -- Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of transformational data-driven solutions to help healthcare providers reduce exposure to risk, enhance clinical, financial, and operational performance, and improve patient care, today announced financial results for the fourth quarter and fiscal year of 2014, which ended January 31, 2015.

Revenues for the three-month period ended January 31, 2015 increased approximately 1.2% to $6.6 million versus $6.5 million in the comparable period of fiscal 2013. Adjusted EBITDA for the fourth quarter was $(0.7) million, up from $(2.2) million in the same period a year ago.

Revenues for fiscal year 2014 were $27.6 million, a 3.1 percent decrease over the previous fiscal year. Recurring revenues for the year were $24.4 million, up 9.4% over fiscal year 2013. Adjusted EBITDA for the fiscal year was $(1.0) million, down from $1.8 million in fiscal year 2013.

"2014 was a difficult year for our company, and for many other companies in our industry, as purchasing slowed down following the most recent phase of Meaningful Use," stated David W. Sides, President and CEO, Streamline Health Solutions, Inc. "A higher level of revenue attrition - nearly twice our historical average - comprised of the loss of some legacy GE clients along with some acquired client relationships negatively affected revenue in 2014 and will affect it in 2015 as well."

"We did, however, establish a new annual record for contract bookings in 2014, and large contracts, such as the ones we signed in Q3 last year, are a very positive development for our company in the long term, although these wins usually take longer to implement and, therefore, longer to recognize revenue. Today our committed, unimplemented quarterly recurring revenue stands at approximately $1.2 million, equating to nearly $5 million in annual revenues that are unrecognized at this time," continued Sides.

"As I look at the challenges and opportunities for our Company, I have implemented three key initiatives that we believe will lead to improved financial performance in 2015 and beyond, as follows. First, grow sales - both inside our existing client base and outside - and focus on improving our client retention. To augment our selling efforts, besides the addition of more sales people and in-house lead generation resources already accomplished, we are looking to expand and better manage strategic channel partners to help sell our solutions to more clients faster. Second, we will complete the links among the solutions inside our Looking Glass® platform to improve the user experience for those who have more than one of our software modules and to aid in cross-selling to our current clients. Third, we will improve our professional services performance to deliver a meaningful contribution to revenue and profit."

"Our clients are some of the most well-regarded healthcare providers in the industry. Our job - and our most immediate opportunity for growth - is to provide them with industry-leading solutions that help make their lives easier, and the performance of their institutions better."

Highlights for the fourth quarter and fiscal year ended January 31, 2015 included:

Revenues for the fourth quarter 2014 were $6.6 million, and for the year were $27.6 million;
Adjusted EBITDA for the fourth quarter 2014 was $(0.7) million, and for the year was $(1.0) million;
Recorded net loss of $(4.8) million for the three-month period ended January 31, 2015, and $(12.0) million for the fiscal year 2014;
Maintenance and support revenues for the quarter increased $0.3 million over the same period one year ago, and were $16.2 million for fiscal year 2014 up 16% over fiscal year 2013;
New sales bookings for the quarter were $0.3 million and $24.0 million for the fiscal year; and
Backlog at the end of the quarter was $72.5 million.

The Company will conduct a conference call to review the results on Thursday, April 16, 2015 at 5:00 PM ET. Interested parties can access the call by dialing 888-337-8169 and then entering Conference ID 8280083. A live webcast will also be available; click here to register.

A replay of the conference call will be available from Thursday, April 16, 2015 at 8:00 PM ET to Tuesday, April 21, 2015 at 8:00 PM ET by dialing 888-203-1112 and entering passcode 8280083.

*Non-GAAP Financial Measures

Streamline Health reports its financial results in accordance with U.S. generally accepted accounting principles ("GAAP"). Streamline Health's management also evaluates and makes operating decisions using various other measures. One such measure is adjusted EBITDA, which is a non-GAAP financial measure. Streamline Health's management believes that this measure provides useful supplemental information regarding the performance of Streamline Health's business operations.

Streamline Health defines "adjusted EBITDA" as net earnings (loss) plus interest expense, tax expense, depreciation and amortization expense of tangible and intangible assets, stock-based compensation expense, significant non-recurring operating expenses, and transactional related expenses including: gains and losses on debt and equity conversions, associate severances and related restructuring expenses, associate inducements, and professional and advisory fees . A table illustrating this measure is included in this press release.

About Streamline Health
Streamline Health Solutions, Inc. (NASDAQ: STRM) is a healthcare industry leader in capturing, aggregating, and translating enterprise data into knowledge -- actionable insights that reduce exposure to risk, enhance operational performance, and improve patient care. Through our Looking Glass™ Platform we provide clients with meaningful, intelligent SaaS-based solutions from patient engagement to reimbursement. We share a common calling and commitment to advance the quality of life and the quality of healthcare -- for society, our industry, our clients, the communities they serve, and the individual patient. For more information, please visit our website at www.streamlinehealth.net.

Safe Harbor statement under the Private Securities Litigation Reform Act of 1995
Statements made by Streamline Health Solutions, Inc. that are not historical facts are forward-looking statements that are subject to certain risks, uncertainties and important factors that could cause actual results to differ materially from those reflected in the forward-looking statements included herein. Forward-looking statements contained in this press release include, without limitation, statements regarding the Company's estimates of future revenue, backlog, renewal sales, interoperability among the Company's solutions, new client sales, success of the Company's channel partner relationships and related expectations and assumptions. These risks and uncertainties include, but are not limited to, the timing of contract negotiations and execution of contracts and the related timing of the revenue recognition related thereto, the potential cancellation of existing contracts or clients not completing projects included in the backlog, the impact of competitive solutions and pricing, solution demand and market acceptance, new solution development and enhancement of current solutions, key strategic alliances with vendors and channel partners that resell the Company's solutions, the ability of the Company to control costs, availability of solutions from third party vendors, the healthcare regulatory environment, potential changes in legislation, regulation and government funding affecting the healthcare industry, healthcare information systems budgets, availability of healthcare information systems trained personnel for implementation of new systems, as well as maintenance of legacy systems, fluctuations in operating results, effects of critical accounting policies and judgments, changes in accounting policies or procedures as may be required by the Financial Accounting Standards Board or other similar entities, changes in economic, business and market conditions impacting the healthcare industry generally and the markets in which the Company operates and nationally, and the Company's ability to maintain compliance with the terms of its credit facilities, and other risks detailed from time to time in the Streamline Health Solutions, Inc. filings with the U. S. Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management's analysis only as of the date hereof. The Company undertakes no obligation to publicly release the results of any revision to these forward-looking statements, which may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.

Company Contact:
Randy Salisbury
SVP, Chief Marketing Officer
(404) 229-4242
randy.salisbury@streamlinehealth.net

STREAMLINE HEALTH SOLUTIONS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

		Three Months Ended January 31,				Fiscal Year Ended
		2015		2014		2015		2014
Revenues:
Systems sales	$	215,670	$	333,723	$	1,214,879	$	3,239,569
Professional services		848,279		716,178		2,580,167		3,641,731
Maintenance and support		3,745,952		3,461,971		16,157,371		13,986,566
Software as a service		1,785,622		2,004,600		7,672,990		7,626,837
Total revenues		6,595,523		6,516,472		27,625,407		28,494,703

Operating expenses:
Cost of systems sales		1,031,305		830,587		3,536,495		3,142,525
Cost of services		1,012,518		948,677		3,458,984		4,052,113
Cost of maintenance and support		534,662		940,549		3,087,842		3,460,500
Cost of software as a service		807,013		909,967		2,920,403		2,523,184
Selling, general and administrative		3,299,977		4,228,140		16,225,574		14,546,335
Research and development		2,905,233		3,460,743		9,756,206		7,088,077
Impairment of intangible assets		1,952,000		-		1,952,000		-
Total operating expenses		11,542,708		11,318,663		40,937,504		34,812,734
Operating loss		(4,947,185)		(4,802,191)		(13,312,097)		(6,318,031)
Other income (expense):
Interest expense		(225,370)		(31,049)		(748,969)		(1,765,813)
Loss on early extinguishment of debt		(315,327)		(160,713)		(429,849)		(160,713)
Miscellaneous income (expenses)		(211,060)		2,787,828		1,592,449		(3,573,091)
Loss before income taxes		(5,698,942)		(2,206,125)		(12,898,466)		(11,817,648)
Income tax benefit		889,299		259,403		887,009		100,459
Net loss	$	(4,809,643)	$	(1,946,722)	$	(12,011,457)	$	(11,717,190)
Less: deemed dividends on Series A Preferred Shares		(286,809)		(449,595)		(1,038,310)		(1,180,904)
Net loss attributable to common shareholders	$	(5,096,452)	$	(2,396,317)	$	(13,049,767)	$	(12,898,094)
Basic net loss per common share	$	(0.28)	$	(0.14)	$	(0.71)	$	(0.94)
Number of shares used in basic per common share computation		18,417,100		16,337,000		18,261,800		13,747,700
Diluted net loss per common share	$	(0.28)	$	(0.14)	$	(0.71)	$	(0.94)
Number of shares used in diluted per common share computation		18,417,100		16,337,000		18,261,800		13,747,700

STREAMLINE HEALTH SOLUTIONS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS

Assets

		January 31,
		2015		2014
Current assets:
Cash and cash equivalents	$	6,522,600	$	17,924,886
Accounts receivable, net of allowance for doubtful
accounts of $665,962 and $267,264, respectively		6,935,270		7,999,571
Contract receivables		191,465		1,181,606
Prepaid hardware and third party software for
future delivery		55,173		25,640
Prepaid client maintenance contracts		935,858		909,464
Other prepaid assets		1,437,680		1,407,515
Deferred income taxes		220,004		95,498
Other current assets		207,673		144,049
Total current assets		16,505,723		29,688,229

Non-current assets:
Property and equipment:
Computer equipment		2,381,923		3,769,564
Computer software		964,857		2,239,654
Office furniture, fixtures and equipment		683,443		889,080
Leasehold improvements		724,015		697,570
		4,754,238		7,595,868
Accumulated depreciation and amortization		(1,617,423)		(6,676,824)
Property and equipment, net		3,136,815		919,044

Contract receivables, less current portion		43,553		78,395
Capitalized software development costs, net of
accumulated amortization of $11,846,468 and
$7,949,352 respectively		9,197,118		10,238,357
Intangible assets, net of accumulated amortization
of $13,677 and $98,102, respectively		9,500,317		12,175,634
Deferred financing costs		387,199		44,898
Goodwill		16,184,667		11,933,683
Other		823,723		500,634
Total non-current assets		39,273,392		35,890,645
	$	55,779,115	$	65,578,874

STREAMLINE HEALTH SOLUTIONS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS

Liabilities and Stockholders' Equity

		January 31,
		2015		2014
Current liabilities:
Accounts payable	$	2,298,851	$	1,796,418
Accrued compensation		865,865		1,782,599
Accrued other expenses		563,838		554,877
Current portion of long-term debt		500,000		1,214,280
Deferred revenues		9,289,076		9,658,232
Current portion of note payable		-		300,000
Current portion of capital lease obligation		781,961		105,573
Total current liabilities		14,299,591		15,411,979

Non-current liabilities:
Term loans		9,500,000		6,971,767
Warrants liability		1,834,380		4,117,725
Royalty liability		2,385,826		2,264,000
Swap contract		-		111,086
Note payable		-		600,000
Lease incentive liability, less current portion		342,129		74,434
Capital lease obligation		582,911		121,089
Deferred revenues, less current portion		964,933		-
Deferred income tax liability, less current portion		229,579		816,079
Total non-current liabilities		15,839,758		15,076,180
Total liabilities		30,139,349		30,488,159

Series A 0% Convertible Redeemable Preferred stock, $.01 par value per share, $8,849,985 redemption value, 4,000,000 shares authorized, 2,949,995 issued and outstanding, net of unamortized preferred stock discount of $2,212,007 and $3,250,317, respectively		6,637,978		5,599,668

Stockholders' equity:
Common stock, $.01 par value per share, 45,000,000 shares
authorized, 18,553,389 and 18,175,787 shares issued and
outstanding, respectively		185,534		181,758
Convertible redeemable preferred stock, $.01 par value per
Additional paid in capital		78,390,424		76,983,088
Accumulated deficit		(59,574,170)		(47,562,713)
Accumulated other comprehensive loss		-		(111,086)
Total stockholders' equity		19,001,788		29,491,047
	$	55,779,115	$	65,578,874

STREAMLINE HEALTH SOLUTIONS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

		Fiscal Year
		2014		2013
Operating activities:
Net loss	$	(12,011,457)	$	(11,717,190)
Adjustments to reconcile net loss to net cash (used in) provided by
operating activities:
Depreciation		1,005,283		718,097
Amortization of capitalized software development costs		3,677,991		3,192,157
Amortization of intangible assets		1,396,317		1,341,734
Amortization of other deferred costs		189,107		385,461
Amortization of debt discounts		47,552		4,327
Valuation adjustment for warrants liability		(2,283,345)		(140,928)
Deferred tax expense (benefit)		(720,582)		20,885
Valuation adjustment for contingent earn-out		-		3,580,441
Other valuation adjustments		128,855		(95,368)
Loss on impairment of intangible assets		1,952,000
Loss from early extinguishment of debt		315,327		160,713
Loss on disposal of fixed assets		180,793		-
Loss on exit of operating lease		234,823		-
Share-based compensation expense		1,934,298		1,660,598
Provision for accounts receivable		440,771		330,907
Changes in assets and liabilities, net of assets acquired:
Accounts and contract receivables		2,157,977		827,435
Other assets		(637,348)		(439,477)
Accounts payable		600,263		275,360
Accrued expenses		(1,422,571)		259,771
Deferred revenues		(197,698)		(152,210)
Net cash (used in) provided by operating activities		(3,011,644)		212,713

Investing activities:
Purchases of property and equipment		(2,125,240)		(152,283)
Capitalization of software development costs		(619,752)		(614,028)
Payment for acquisition, net of cash acquired		(6,058,225)		(3,000,000)
Net cash used in investing activities		(8,803,217)		(3,766,311)

Financing activities:
Proceeds from term loan		10,000,000		4,958,333
Principal repayments on term loan		(8,297,620)		(10,348,214)
Principal repayments on note payable		(900,000)		-
Principal payments on capital lease obligation		(368,386)		(34,391)
Payment of deferred financing costs		(573,002)		(115,900)
Proceeds from exercise of stock options and stock purchase plan		551,583		1,356,060
Settlement of earn-out consideration		-		(1,300,000)
Proceeds from the sale of common stock		-		20,586,619
Payment of debt success fee		-		(1,124,279)
Net cash provided by (used in) financing activities		412,575		13,978,228
(Decrease) increase in cash and cash equivalents		(11,402,286)		10,424,630
Cash and cash equivalents at beginning of year		17,924,886		7,500,256
Cash and cash equivalents at end of year	$	6,522,600	$	17,924,886

STREAMLINE HEALTH SOLUTIONS, INC.
Backlog
(Unaudited)
Table A

		January 31, 2015		October 31, 2014		January 31, 2014
Streamline Health Software Licenses	$	20,888,000	$	21,103,000	$	2,230,000
Hardware and Third Party Software		244,000		126,000		79,000
Professional Services		7,485,000		8,095,000		7,255,000
Maintenance and Support		21,304,000		21,657,000		25,936,000
Software as a Service		22,574,000		24,928,000		21,073,000
Total	$	72,495,000	$	75,909,000	$	56,573,000

STREAMLINE HEALTH SOLUTIONS, INC.
New Bookings
(Unaudited)
Table B

		Fiscal Year Ended
		January 31, 2015
		Value	% of Total Bookings
Streamline Health Software licenses	$	19,842,000	83%
Software as a service		1,163,000	5%
Maintenance and support		102,000	0%
Professional services		2,882,000	12%
Hardware & third party software		52,000	0%
Total bookings	$	24,041,000	100%

Reconciliation of Non-GAAP Financial Measures
Table C

This press release contains a non-GAAP financial measure under the rules of the U.S. Securities and Exchange Commission for adjusted EBITDA. This non-GAAP information supplements and is not intended to represent a measure of performance in accordance with disclosures required by generally accepted accounting principles. Non-GAAP financial measures are used internally to manage the business, such as in establishing an annual operating budget. Non-GAAP financial measures are used by Streamline Health's management in its operating and financial decision-making because management believes these measures reflect ongoing business in a manner that allows meaningful period-to-period comparisons. Accordingly, the Company believes it is useful for investors and others to review both GAAP and non-GAAP measures in order to (a) understand and evaluate current operating performance and future prospects in the same manner as management does and (b) compare in a consistent manner the Company's current financial results with past financial results. The primary limitations associated with the use of non-GAAP financial measures are that these measures may not be directly comparable to the amounts reported by other companies and they do not include all items of income and expense that affect operations. The Company's management compensates for these limitations by considering the company's financial results and outlook as determined in accordance with GAAP and by providing a detailed reconciliation of the non-GAAP financial measures to the most directly comparable GAAP measures in the tables attached to this press release. Streamline Health defines "adjusted EBITDA" as net earnings (loss) plus interest expense, tax expense, depreciation and amortization expense of tangible and intangible assets, stock-based compensation expense, significant non-recurring operating expenses, and transactional related expenses including: gains and losses on debt and equity conversions, associate severances and related restructuring expenses, associate inducements, professional and advisory fees, and internal direct costs incurred to complete transactions.

Reconciliation of net earnings (loss) to non-GAAP adjusted EBITDA (in thousands):

Adjusted EBITDA Reconciliation		Three Months Ended,				Twelve Months Ended,
		January 31, 2015		January 31, 2014		January 31, 2015		January 31, 2014
Net loss	$	(4,809)	$	(1,947)	$	(12,011)	$	(11,717)
Interest expense		225		31		749		1,766
Income tax benefit		(889)		(259)		(887)		(100)
Depreciation		334		228		1,005		718
Amortization of capitalized software development costs		942		1,105		3,678		3,192
Amortization of intangible assets		345		398		1,396		1,342
Amortization of other costs		45		24		166		74
EBITDA		(3,807)		(419)		(5,904)		(4,725)
Share-based compensation expense		648		457		1,934		1,661
Loss on impairment of intangibles		1,952		-		1,952		-
Loss on early extinguishment of debt		315		161		430		161
Loss on disposal of fixed assets		70		-		181		-
Non-cash valuation adjustments to assets and liabilities		52		(2,796)		(2,154)		3,427
Transaction related professional fees, advisory fees and
other internal direct costs		6		406		182		769
Associate severances and other costs relating to
transactions or corporate restructuring		70		32		901		415
Other non-recurring operating expenses		0		9		1,491		62
Adjusted EBITDA	$	(694)	$	(2,150)	$	(987)	$	1,771
Adjusted EBITDA per diluted share
Loss per share - diluted	$	(0.28)	$	(0.15)	$	(0.71)	$	(0.94)
Adjusted EBITDA per adjusted diluted share ⁽¹⁾	$	(0.04)	$	(0.13)	$	(0.05)	$	0.10

Diluted weighted average shares		18,417,100		16,336,668		18,261,800		13,747,700
Includable incremental shares — adjusted EBITDA ⁽²⁾		-		-		-		4,863,140
Adjusted diluted shares		18,417,100		16,336,668		18,261,800		18,610,840


(1)	Adjusted EBITDA per adjusted diluted share for the Company's common stock is computed using the more dilutive of the two-class method or the if-converted method.
(2)	The number of incremental shares that would be dilutive under profit assumption, only applicable under a GAAP net loss. If GAAP profit is earned in the current period, no additional incremental shares are assumed.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/streamline-health-reports-fourth-quarter-2014-revenues-of-66-million-2014-recurring-revenues-of-88-300067515.html

SOURCE Streamline Health Solutions, Inc.

News Provided by Acquire Media